These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 26875818)

  • 1. Simvastatin and atorvastatin facilitates amyloid β-protein degradation in extracellular spaces by increasing neprilysin secretion from astrocytes through activation of MAPK/Erk1/2 pathways.
    Yamamoto N; Fujii Y; Kasahara R; Tanida M; Ohora K; Ono Y; Suzuki K; Sobue K
    Glia; 2016 Jun; 64(6):952-62. PubMed ID: 26875818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigallocatechin gallate induces extracellular degradation of amyloid β-protein by increasing neprilysin secretion from astrocytes through activation of ERK and PI3K pathways.
    Yamamoto N; Shibata M; Ishikuro R; Tanida M; Taniguchi Y; Ikeda-Matsuo Y; Sobue K
    Neuroscience; 2017 Oct; 362():70-78. PubMed ID: 28844000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-signaling Pathway Regulates the Degradation of Amyloid β-protein via Astrocytes.
    Yamamoto N; Ishikuro R; Tanida M; Suzuki K; Ikeda-Matsuo Y; Sobue K
    Neuroscience; 2018 Aug; 385():227-236. PubMed ID: 29932983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptin inhibits amyloid β-protein degradation through decrease of neprilysin expression in primary cultured astrocytes.
    Yamamoto N; Tanida M; Ono Y; Kasahara R; Fujii Y; Ohora K; Suzuki K; Sobue K
    Biochem Biophys Res Commun; 2014 Feb; 445(1):214-7. PubMed ID: 24508800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine reduces amyloid β-protein degradation by suppressing neprilysin expression in primary cultured astrocytes.
    Yamamoto N; Arima H; Naruse K; Kasahara R; Taniura H; Hirate H; Sugiura T; Suzuki K; Sobue K
    Neurosci Lett; 2013 Jun; 545():54-8. PubMed ID: 23624023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins induce insulin-degrading enzyme secretion from astrocytes via an autophagy-based unconventional secretory pathway.
    Son SM; Kang S; Choi H; Mook-Jung I
    Mol Neurodegener; 2015 Oct; 10():56. PubMed ID: 26520569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative inactivation of amyloid beta-degrading proteases by cholesterol-enhanced mitochondrial stress.
    de Dios C; Bartolessis I; Roca-Agujetas V; Barbero-Camps E; Mari M; Morales A; Colell A
    Redox Biol; 2019 Sep; 26():101283. PubMed ID: 31376793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(I:C) promotes neurotoxic amyloid β accumulation through reduced degradation by decreasing neprilysin protein levels in astrocytes.
    Yamamoto N; Tokumon T; Obuchi A; Kono M; Saigo K; Tanida M; Ikeda-Matsuo Y; Sobue K
    J Neurochem; 2022 Dec; 163(6):517-530. PubMed ID: 36321194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of amyloid associated proteins on the expression of genes involved in amyloid-β clearance by adult human astrocytes.
    Mulder SD; Veerhuis R; Blankenstein MA; Nielsen HM
    Exp Neurol; 2012 Jan; 233(1):373-9. PubMed ID: 22101005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinases A and C regulate amyloid-β degradation by modulating protein levels of neprilysin and insulin-degrading enzyme in astrocytes.
    Yamamoto N; Nakazawa M; Nunono N; Yoshida N; Obuchi A; Tanida M; Suzuki K; Ikeda-Matsuo Y; Sobue K
    Neurosci Res; 2021 May; 166():62-72. PubMed ID: 32512031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
    Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
    J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell surface expression of the major amyloid-β peptide (Aβ)-degrading enzyme, neprilysin, depends on phosphorylation by mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (MEK) and dephosphorylation by protein phosphatase 1a.
    Kakiya N; Saito T; Nilsson P; Matsuba Y; Tsubuki S; Takei N; Nawa H; Saido TC
    J Biol Chem; 2012 Aug; 287(35):29362-72. PubMed ID: 22767595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
    Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS
    Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-degrading enzyme secretion from astrocytes is mediated by an autophagy-based unconventional secretory pathway in Alzheimer disease.
    Son SM; Cha MY; Choi H; Kang S; Choi H; Lee MS; Park SA; Mook-Jung I
    Autophagy; 2016 May; 12(5):784-800. PubMed ID: 26963025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PKCε promotes HuD-mediated neprilysin mRNA stability and enhances neprilysin-induced Aβ degradation in brain neurons.
    Lim CS; Alkon DL
    PLoS One; 2014; 9(5):e97756. PubMed ID: 24848988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irisin reduces amyloid-β by inducing the release of neprilysin from astrocytes following downregulation of ERK-STAT3 signaling.
    Kim E; Kim H; Jedrychowski MP; Bakiasi G; Park J; Kruskop J; Choi Y; Kwak SS; Quinti L; Kim DY; Wrann CD; Spiegelman BM; Tanzi RE; Choi SH
    Neuron; 2023 Nov; 111(22):3619-3633.e8. PubMed ID: 37689059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Messenger RNA-based therapeutics for brain diseases: An animal study for augmenting clearance of beta-amyloid by intracerebral administration of neprilysin mRNA loaded in polyplex nanomicelles.
    Lin CY; Perche F; Ikegami M; Uchida S; Kataoka K; Itaka K
    J Control Release; 2016 Aug; 235():268-275. PubMed ID: 27282413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice.
    Devi L; Ohno M
    Mol Brain; 2015 Mar; 8():19. PubMed ID: 25884928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HIAA induces neprilysin to ameliorate pathophysiology and symptoms in a mouse model for Alzheimer's disease.
    Klein C; Roussel G; Brun S; Rusu C; Patte-Mensah C; Maitre M; Mensah-Nyagan AG
    Acta Neuropathol Commun; 2018 Dec; 6(1):136. PubMed ID: 30537985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.